Family Management Corp Abbott Laboratories Transaction History

Family Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $174,029 - $210,345	-1,705 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $4,788 - $5,839	42 Added 2.53%	1,705 $202,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $43,323 - $53,047	-375 Reduced 18.4%	1,663 $234,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $15,632 - $17,294	-134 Reduced 6.17%	2,038 $241,000
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $8,040 - $9,464	76 Added 3.63%	2,172 $252,000
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $13,387 - $15,772	-123 Reduced 5.54%	2,096 $251,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $15,015 - $16,362	143 Added 6.89%	2,219 $243,000
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $143,599 - $174,391	-1,567 Reduced 43.01%	2,076 $226,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $5,359 - $6,860	70 Added 1.96%	3,643 $333,000
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $6,156 - $9,002	98 Added 2.82%	3,573 $282,000
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $272,822 - $303,715	3,475 New	3,475 $302,000

3,135

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

Stay updated on Family Management Corp with notifications on news.